News Headline Summary

MAP Pharmaceuticals (MAPP) investor sues over Allergan acquisition; says offer of USD 958mln undervalues MAP

Reaction details:

- No immediate reaction in MAPP shares, last trade at USD 24.74.

Print 19:17, 31 Jan 2013 - US Equities - Source: Newswires